SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2694Millennium Pharmaceuticals "neutral," estimates reduced Wednesday, SeIcebrg-9/20/2006
2693{Velcade and geldanamycin MOA} Message 22812274 Cheers, Tucktuck-9/14/2006
2692Ooops, perhaps I should have waited another day before writing a covered call...Ian@SI-8/30/2006
2691Velcade interferes with Docetaxel? >>Mol Cancer Ther. 2006 Aug;5(8):2043-tuck-8/25/2006
2690Millennium Pharmaceuticals "neutral" Monday, August 21, 2006 3:46:28 Icebrg-8/21/2006
2689.....Laurie Bartlett Keating, Millennium's general counsel, said the cancer Icebrg-8/11/2006
2688Citi: MLNM: Velcade Growing, But Competition Is Here HOLD (2) Speculativmopgcw-8/11/2006
2687gs: Millennium Pharmaceuticals, Inc. (MLNM): Strong 2Q2006 helped by solid Velcamopgcw-8/11/2006
2686Longitudinally Quantitative 2-Deoxy-2-[(18)F]fluoro-D: -glucose Micro Positron EIcebrg-8/11/2006
2685"Web site sucks." Tell them what you don't like about it. They mitechnetium-8/10/2006
2684"IND status generally connotes that there have been animal studies, where atechnetium-8/10/2006
2683John, I believe your and Peter's comments about AVII on the Valuation threaIan@SI-8/10/2006
2682Maybe Peter and I over-emphasized comments earlier today about lack of animal daJohn Metcalf-8/9/2006
2681Clinical trial was started this May -- or at least, a PR stated that a Ph I hasIan@SI-8/9/2006
2680A somewhat weird abstract... <i>... a new irreversible proteasome inhibitIan@SI-8/9/2006
2679Velcade competition -- keeping an eye on NPI-0052: >>Mol Cancer Ther. 200tuck-8/9/2006
2678FDA Grants Priority Review to VELCADE(R) (Bortezomib) for Injection for TreatmenIan@SI-8/9/2006
2677Millennium Pharmaceuticals "neutral," target price raised Friday, JulIcebrg-7/28/2006
2676I guess it was some kind of stupid joke coz the CC went well: today.reuters.comidos-7/27/2006
2675Millennium Pharmaceuticals Earnings Conference Call (Q2 2006) Scheduled to startidos-7/27/2006
2674[Bortezomib and depsipeptide sensitize tumors to TRAIL] >>Cancer Res. 200tuck-7/21/2006
26737:15AM On The Wires : Human Genome Sciences (HGSI) announces that it has initiaIan@SI-7/20/2006
2672Celgene to Price Cancer Medicine At $6,195 a Month By GEETA ANAND July 1, 2006; Ian@SI-7/3/2006
2671Merrill's take: More positive data for Velcade in front-line MM MLNM annountom pope-6/22/2006
2670gs: MLNM (IL/N): Talks on strategic alternatives may resume 52-Week Range US$11mopgcw-6/22/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News